Journal of Dermatological Treatment This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day
J Dermatolog Treat. 2024 Dec;35(1):2316239. doi: 10.1080/09546634.2024.2316239. Epub 2024 Feb 22.NO ABSTRACTPMID:38387442 | DOI:10.1080/09546634.2024.2316239 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 22, 2024 Category: Dermatology Authors: Yuji Kan Hisashi Uhara Source Type: research

Patients' and caregivers' perspectives of the atopic dermatitis journey
CONCLUSION: A holistic assessment of AD includes understanding patient and caregiver preferences, needs, experiences and disease perceptions. Addressing the identified gaps may improve the management of AD.PMID:38387879 | DOI:10.1080/09546634.2024.2315145 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 22, 2024 Category: Dermatology Authors: Steven R Feldman Alson Wai Ming Chan Alfred Ammoury Jianzhong Zhang Akio Tanaka XingXiang Shi Amy Cha Helen Tran Source Type: research

Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide  + etoposide chemotherapy for Ewing Sarcoma: a case report
J Dermatolog Treat. 2024 Dec;35(1):2319303. doi: 10.1080/09546634.2024.2319303. Epub 2024 Feb 20.NO ABSTRACTPMID:38378173 | DOI:10.1080/09546634.2024.2319303 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 20, 2024 Category: Dermatology Authors: Mario Valenti Luigi Gargiulo Luciano Ibba Alexia Bertuzzi Sofia Manara Francesco Toso Antonio Costanzo Alessandra Narcisi Source Type: research

Vitiligo outpatient management in the United States: findings from the 2012-2019 National Ambulatory Medical care Survey (NAMCS)
J Dermatolog Treat. 2024 Dec;35(1):2311793. doi: 10.1080/09546634.2024.2311793. Epub 2024 Feb 11.NO ABSTRACTPMID:38342494 | DOI:10.1080/09546634.2024.2311793 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Gaurav N Pathak Anurag N Pathak Vibha Mital Jimmy Dhillon Steven R Feldman Babar K Rao Source Type: research

Dupliumab therapy for alopecia areata: a case series and review of the literature
CONCLUSIONS: Overall, our research supports dupilumab as another candidate that possesses potential benefits for AA. High levels of IgE may be not prerequisites for dupilumab's successful treatment response.PMID:38342501 | DOI:10.1080/09546634.2024.2312245 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Jundong Huang Jia Jian Tingting Li Min Li Kaifu Luo Sihan Deng Yan Tang Fangfen Liu Zhixiang Zhao Wei Shi Ji Li Source Type: research

Vitiligo outpatient management in the United States: findings from the 2012-2019 National Ambulatory Medical care Survey (NAMCS)
J Dermatolog Treat. 2024 Dec;35(1):2311793. doi: 10.1080/09546634.2024.2311793. Epub 2024 Feb 11.NO ABSTRACTPMID:38342494 | DOI:10.1080/09546634.2024.2311793 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Gaurav N Pathak Anurag N Pathak Vibha Mital Jimmy Dhillon Steven R Feldman Babar K Rao Source Type: research

Dupliumab therapy for alopecia areata: a case series and review of the literature
CONCLUSIONS: Overall, our research supports dupilumab as another candidate that possesses potential benefits for AA. High levels of IgE may be not prerequisites for dupilumab's successful treatment response.PMID:38342501 | DOI:10.1080/09546634.2024.2312245 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Jundong Huang Jia Jian Tingting Li Min Li Kaifu Luo Sihan Deng Yan Tang Fangfen Liu Zhixiang Zhao Wei Shi Ji Li Source Type: research

Vitiligo outpatient management in the United States: findings from the 2012-2019 National Ambulatory Medical care Survey (NAMCS)
J Dermatolog Treat. 2024 Dec;35(1):2311793. doi: 10.1080/09546634.2024.2311793. Epub 2024 Feb 11.NO ABSTRACTPMID:38342494 | DOI:10.1080/09546634.2024.2311793 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Gaurav N Pathak Anurag N Pathak Vibha Mital Jimmy Dhillon Steven R Feldman Babar K Rao Source Type: research

Dupliumab therapy for alopecia areata: a case series and review of the literature
CONCLUSIONS: Overall, our research supports dupilumab as another candidate that possesses potential benefits for AA. High levels of IgE may be not prerequisites for dupilumab's successful treatment response.PMID:38342501 | DOI:10.1080/09546634.2024.2312245 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Jundong Huang Jia Jian Tingting Li Min Li Kaifu Luo Sihan Deng Yan Tang Fangfen Liu Zhixiang Zhao Wei Shi Ji Li Source Type: research

Vitiligo outpatient management in the United States: findings from the 2012-2019 National Ambulatory Medical care Survey (NAMCS)
J Dermatolog Treat. 2024 Dec;35(1):2311793. doi: 10.1080/09546634.2024.2311793. Epub 2024 Feb 11.NO ABSTRACTPMID:38342494 | DOI:10.1080/09546634.2024.2311793 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Gaurav N Pathak Anurag N Pathak Vibha Mital Jimmy Dhillon Steven R Feldman Babar K Rao Source Type: research

Dupliumab therapy for alopecia areata: a case series and review of the literature
CONCLUSIONS: Overall, our research supports dupilumab as another candidate that possesses potential benefits for AA. High levels of IgE may be not prerequisites for dupilumab's successful treatment response.PMID:38342501 | DOI:10.1080/09546634.2024.2312245 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Jundong Huang Jia Jian Tingting Li Min Li Kaifu Luo Sihan Deng Yan Tang Fangfen Liu Zhixiang Zhao Wei Shi Ji Li Source Type: research

Vitiligo outpatient management in the United States: findings from the 2012-2019 National Ambulatory Medical care Survey (NAMCS)
J Dermatolog Treat. 2024 Dec;35(1):2311793. doi: 10.1080/09546634.2024.2311793. Epub 2024 Feb 11.NO ABSTRACTPMID:38342494 | DOI:10.1080/09546634.2024.2311793 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Gaurav N Pathak Anurag N Pathak Vibha Mital Jimmy Dhillon Steven R Feldman Babar K Rao Source Type: research

Dupliumab therapy for alopecia areata: a case series and review of the literature
CONCLUSIONS: Overall, our research supports dupilumab as another candidate that possesses potential benefits for AA. High levels of IgE may be not prerequisites for dupilumab's successful treatment response.PMID:38342501 | DOI:10.1080/09546634.2024.2312245 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 11, 2024 Category: Dermatology Authors: Jundong Huang Jia Jian Tingting Li Min Li Kaifu Luo Sihan Deng Yan Tang Fangfen Liu Zhixiang Zhao Wei Shi Ji Li Source Type: research

Outcomes of extracorporeal photopheresis in a diverse cohort of patients with cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital
J Dermatolog Treat. 2024 Dec;35(1):2312250. doi: 10.1080/09546634.2024.2312250. Epub 2024 Feb 8.NO ABSTRACTPMID:38331434 | DOI:10.1080/09546634.2024.2312250 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 8, 2024 Category: Dermatology Authors: David M Weiner Priyanka Kumar Ravi Varadhan Ronald Sweren Noori Kim Sima Rozati Source Type: research